Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
NCT03647358
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Carcinoma
Metastatic Thyroid Carcinoma
Interventions
DEVICE:
PET/CT Scan
DRUG:
Iodine-124
Sponsor
Memorial Sloan Kettering Cancer Center